In PBMNCs from patients with MPN, JAK2 interacted with CHST15. However, there were some differences in the strength of the interaction, The abundance of CHST15 in familial MPN harboringthe CHST15 mutation was lower than that in sporadic MPN. Here, JAK2 is linked to myeloproliferative neoplasm.